Article Information
- Received July 30, 1998
- Revision received September 17, 1998
- Accepted September 18, 1998
- First published December 1, 1998.
- Version of record published December 1, 1998.
Author Information
- Jonathan K. Ivins1,
- Holly Colognato2,
- Jordan A. Kreidberg3,
- Peter D. Yurchenco2, and
- Arthur D. Lander1
- 1Department of Developmental and Cell Biology and the Developmental Biology Center, University of California at Irvine, Irvine, California 92697,
- 2Department of Pathology and Laboratory Medicine, Robert Wood Johnson Medical School, Piscataway, New Jersey 08854, and
- 3Divisions of Nephrology and Developmental and Newborn Biology, Children’s Hospital and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02115
Author contributions
Disclosures
- Received July 30, 1998.
- Revision received September 17, 1998.
- Accepted September 18, 1998.
This work was supported by National Institutes of Health Grants EY10324 and NS36049 and American Paralysis Association Grant LA2–9603 to A.D.L. and by National Institutes of Health Grant DK48045 to P.D.Y. We wish to thank the following for their generous gifts of antibodies: Mike DiPersio, Richard Hynes, Louis Reichardt, Kelly McNagy, Amy Bradshaw, Sal Carbonetto, and Clayton Buck. Mark Fitchmun and Mary Herndon provided LN-5 and thrombospondin-1, respectively, and Humphrey Gardner provided the PCR protocol for genotyping α3 knock-out mice.
Correspondence should be addressed to Dr. Jonathan K. Ivins, Department of Developmental and Cell Biology and the Developmental Biology Center, University of California at Irvine, Irvine, CA 92697.
Online Impact